1.0Business France at BIO Conventionhttps://event.businessfrance.fr/business-france-at-bio-conventionrich600338<blockquote class="wp-embedded-content" data-secret="1BHbUO0kk0"><a href="https://event.businessfrance.fr/business-france-at-bio-convention/igyxos/">Igyxos</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://event.businessfrance.fr/business-france-at-bio-convention/igyxos/embed/#?secret=1BHbUO0kk0" width="600" height="338" title="« Igyxos » — Business France at BIO Convention" data-secret="1BHbUO0kk0" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://event.businessfrance.fr/business-france-at-bio-convention/wp-includes/js/wp-embed.min.js </script> https://event.businessfrance.fr/business-france-at-bio-convention/wp-content/uploads/sites/1378/2026/04/Design-sans-titre-22-1.png13501350Igyxos is a French biotechnology company dedicated to addressing the growing global need for improved infertility solutions through novel therapeutics that make treatment more effective and efficient for men and women. Igyxos lead asset is IGX12, a first-in-class humanized monoclonal antibody which is Phase 2 ready.